Litcius/Paper detail

Reduced antibody activity against SARS-CoV-2 B.1.617.2 delta virus in serum of mRNA-vaccinated individuals receiving tumor necrosis factor-α inhibitors

Rita E. Chen, Matthew J. Gorman, Daniel Y. Zhu, Juan Manuel Carreño, Dansu Yuan, Laura A. VanBlargan, Samantha Burdess, Douglas A. Lauffenburger, Wooseob Kim, Jackson S. Turner, Lindsay Droit, Scott A. Handley, Salim Chahin, Parakkal Deepak, Jane A. O’Halloran, Michael Paley, Rachel M. Presti, Gregory F. Wu, Florian Krammer, Galit Alter, Ali H. Ellebedy, Alfred H.J. Kim, Michael Diamond

2021Med36 citationsDOIOpen Access PDF

Topics & Concepts

MedicineImmunologyAntibodyNeutralizing antibodyImmunosuppressionAntibody titerVirusImmunizationImmune systemVirologyContext (archaeology)VaccinationTumor necrosis factor alphaViral sheddingTiterNeutralizationBiologyPaleontologySARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studiesvaccines and immunoinformatics approaches